Austria: Wolf Theiss Advises Audax Private Equity on Acquisition of Avantor’s Clinical Services business

IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


Austria: Wolf Theiss Advises Audax Private Equity on Acquisition of Avantor’s Clinical Services business

Sponsored by

22WolfTheiss.png

Prague, 21 August 2024 – Wolf Theiss assisted Audax Private Equity, a leading middle market investment firm based in Boston and San Francisco, with its acquisition of Avantor’s Clinical Services business.

Prague, 21 August 2024 – Wolf Theiss assisted Audax Private Equity, a leading middle market investment firm based in Boston and San Francisco, with its acquisition of Avantor’s Clinical Services business.

The Wolf Theiss team, working alongside Ropes & Gray LLP, advised Audax Private Equity on all Czech legal and regulatory aspects related to the acquisition of the Clinical Services business, a part of Avantor Inc. Clinical Services provides clinical trial and laboratory supply chain services to pharmaceutical and biotechnology companies, contract research organisations and diagnostic laboratories. The transaction’s value is approximately $650 million.

The transaction team was led by Tereza Naučová (Counsel, Prague) and further included Maroš Kandrík (Associate, Prague), Ondřej Beneš (Counsel, Prague), Tomáš Kren (Counsel, Prague), Kamila Seberová (Counsel, Prague), Michal Matouš (Senior Associate) and Nikola Hnojilová (Associate, Prague).

Gift this article